Drug Discovery Technology Alert. Miotoxicity and Drug Screening Assays through Micropatterning Techniques; Leveraging Glycobioengineering for Cancer Research; Pharmacological Chaperones to Enhance Enzyme Replacement Therapies

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue profiles miotoxicity and drug screening assays through micropatterning techniques, leveraging glycobioengineering for cancer research, and pharmacological chaperones to enhance enzyme replacement therapies.

Table of Contents

Drug Discovery Technology Alert. Miotoxicity and Drug Screening Assays through Micropatterning Techniques; Leveraging Glycobioengineering for Cancer Research; Pharmacological Chaperones to Enhance Enzyme Replacement TherapiesIn This Issue1. NOCICEPTORS FOR THE TREATMENT OF PAIN2. MIOTOXICITY AND DRUG SCREENING ASSAYS THROUGH MICROPATTERNING TECHNIQUES3. LEVERAGING GLYCOBIOENGINEERING FOR CANCER RESEARCH4. FLUORINATION CHEMISTRY PLATFORM TECHNOLOGY ADVANCING CLINICAL TRIALS FOR DIABETES 5. PHARMACOLOGICAL CHAPERONES TO ENHANCE ENZYME REPLACEMENT THERAPIES6. ENHANCING STEM CELL BIODISTRUBUTION AND HOMING 7. ENHANCING ANIONIC DRUG DELIVERY THROUGH NANOBIOTECH PLATFORMS8. GLOBAL PATENTS ON LYSOSOMAL STORAGE DISORDERS9. TECHVISION 2015




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.